ProMIS Neurosciences, Inc. (PMN)
NASDAQ: PMN · Real-Time Price · USD
14.96
+0.35 (2.40%)
At close: Feb 12, 2026, 4:00 PM EST
14.65
-0.31 (-2.07%)
After-hours: Feb 12, 2026, 5:47 PM EST
ProMIS Neurosciences Market Cap
ProMIS Neurosciences has a market cap or net worth of $32.2 million as of February 12, 2026. Its market cap has increased by 10.17% in one year.
Market Cap
32.20M
Enterprise Value
16.77M
1-Year Change
10.17%
Ranking
Category
Stock Price
$14.96
Market Cap Chart
Since April 16, 2012, ProMIS Neurosciences's market cap has increased from $21.82M to $32.20M, an increase of 47.56%. That is a compound annual growth rate of 2.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 32.20M | 119.19% |
| Dec 31, 2025 | 14.69M | -52.59% |
| Dec 31, 2024 | 30.98M | 42.66% |
| Dec 29, 2023 | 21.72M | -41.67% |
| Dec 30, 2022 | 37.23M | -24.28% |
| Dec 31, 2021 | 49.17M | 104.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Atossa Therapeutics | 32.64M |
| OnKure Therapeutics | 32.52M |
| NeuroSense Therapeutics | 32.12M |
| Hyperion DeFi | 32.08M |
| Werewolf Therapeutics | 31.91M |
| Atara Biotherapeutics | 31.58M |
| Tempest Therapeutics | 31.55M |
| Kyntra Bio | 30.95M |